ChromaDex Corp
For the period ended Jun 30, 2024. Filed Aug 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2024
Commission File Number:001-37752
CHROMADEX CORPORATION
(Exact Name of Registrant as Specified in its Charter)
| Delaware | 26-2940963 |
|---|---|
| (State or other jurisdiction ofincorporation or organization) | (I.R.S. EmployerIdentification No.) |
| 10900 Wilshire Blvd. Suite 600, Los Angeles, California | 90024 |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant's telephone number, including area code: (310)388-6706
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of Each exchange on which registered |
|---|---|---|
| Common Stock, $0.001 par value per share | CDXC | The Nasdaq Capital Market |
| Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. | ☑ | Yes | ☐ | No | |||||
|---|---|---|---|---|---|---|---|---|---|
| Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). | ☑ | Yes | ☐ | No | |||||
| Indicate by check mark whether the registrant is a large accelerated filer, accelerated filer, non-accelerated filer, smaller reporting company or emerging growth company. See definition of “large accelerated filer, accelerated filer, smaller reporting company and emerging growth company” in Rule 12b-2 of the Exchange Act. | |||||||||
| Large accelerated filer | ☐ | Accelerated filer | ☐ | Non-accelerated filer | ☑ | Smaller reporting company | ☑ | Emerging growth company | ☐ |
| If an emerging growth company, indicate if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | Yes | ☐ | No | |||||
| Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). | ☐ | Yes | ☑ | No | |||||
As of August 5, 2024 there were 75,933,137 shares of the registrant’s common stock issued and outstanding.
ChromaDex Corporation
Quarterly Report on Form 10-Q
For the Three and Six Months Ended June 30, 2024
| PART I - Financial Information (unaudited) | Pg. |
|---|---|
| Item 1. Financial Statements (unaudited): | 3 |
| Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 | 3 |
| Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and June 30, 2023 | 4 |
| Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended June 30, 2024 and June 30, 2023 | 5 |
| Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and June 30, 2023 | 7 |
| Notes to Condensed Consolidated Financial Statements | 8 |
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 27 |
| Item 3. Quantitative and Qualitative Disclosures About Market Risk | 34 |
| Item 4. Controls and Procedures | 34 |
| PART II - Other Information | |
| Item 1. Legal Proceedings | 34 |
| Item 1A. Risk Factors | 36 |
| Item 5. Other information | 58 |
| Item 6. Exhibits | 59 |
| Signatures | 60 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.